Objectives
Previously we reported that annexin 2 (anxa2) plays an important role in hematopoietic stem cell (HSC) localization to the endosteal/osteoblastic marrow niche. The study explored the role that annexin 2 plays in presenting stromal derived factor-1 (SDF-1 or CXCL12) to HSCs.
Materials and Methods
Competitive long-term bone marrow transplant (CLT-BMT) assays were used to determine if HSC engraftment is altered in annexin 2-deficient animals. Colony-forming cell assays, CXCL12 Elisa, and real-time RT-PCR analyses were employed to determine stem or progenitor cell mobilization by G-CSF. Immunohistochemistry, immunoprecipitation, binding assays, and chemotactic assays were employed to determine if annexin 2 is associated with CXCL12. Degradation assays were also used to determine if annexin 2 and CXCL12 protect each other from proteolytic degradation.
Results
Anxa2−/− animals have fewer HSC in their marrows, and the HSCs in anxa2−/− animals express less CXCR4 and CXCR7 suggesting a cell intrinsic defect. Transplantation studies of wild-type marrow into anxa2−/− animals demonstrated a cell extrinsic defect in the anxa2−/− animals. CXCL12 binds directly to annexin 2, and this interaction facilitates the presentation of CXCL12 to HSCs. Yet the binding of CXCL12 to annexin 2 does not protect CXCL12 from proteolytic cleavage following stem or progenitor cell mobilization by G-CSF.
Conclusions
These results suggest that annexin 2 serves as an anchor for CXCL12 to help in the localization of HSCs to the niche.